Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Rullan

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cell|April 18, 2020
SnapShot: Cancer-Associated FibroblastsDanielle Park, Erik Sahai, Antonio Rullan
Frontiers in Oncology|October 31, 2022
A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancerAmy Burley, Antonio Rullan, Anna Wilkins
Cancer Research|December 26, 2019
Topological Tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma HistologyHenrik Failmezger, Sathya Muralidhar, Antonio Rullan, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 6, 2022
Introducing Checkpoint Inhibitors Into the Curative Setting of Head and Neck Cancers: Lessons Learned, Future ConsiderationsPablo Nenclares, Antonio Rullan, Kenric Tam, et al.
Frontiers in Oncology|September 15, 2022
Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapyCharleen M L Chan Wah Hak, Antonio Rullan, Emmanuel C Patin, et al.
Cancer Treatment Reviews|May 31, 2024
A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapiesPablo Jiménez-Labaig, Antonio Rullan, Alberto Hernando-Calvo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 25, 2024
Prevalence of depressive and anxiety symptoms in patients with head and neck cancer undergoing radiotherapy: A systematic review and meta-analysis of longitudinal studiesPablo Jiménez-Labaig, Claudia Aymerich, Antonio Rullan, et al.
JNCI Cancer Spectrum|May 3, 2024
A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysisPablo Jimenez-Labaig, Claudia Aymerich, Irene Braña, et al.
Journal for Immunotherapy of Cancer|November 28, 2025
Second-event endpoints (EFS2, PRFS2 and PFS2) after anti-PD-(L)1-based RCTs: a systematic review and meta-analysisPablo Jimenez-Labaig, Oriol Mirallas, Ana Isabel Martin-Quesada, et al.
Nature Cell Biology|June 3, 2020
STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapyEsther N Arwert, Emma L Milford, Antonio Rullan, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cell|April 18, 2020
SnapShot: Cancer-Associated FibroblastsDanielle Park, Erik Sahai, Antonio Rullan
Frontiers in Oncology|October 31, 2022
A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancerAmy Burley, Antonio Rullan, Anna Wilkins
Cancer Research|December 26, 2019
Topological Tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma HistologyHenrik Failmezger, Sathya Muralidhar, Antonio Rullan, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 6, 2022
Introducing Checkpoint Inhibitors Into the Curative Setting of Head and Neck Cancers: Lessons Learned, Future ConsiderationsPablo Nenclares, Antonio Rullan, Kenric Tam, et al.
Frontiers in Oncology|September 15, 2022
Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapyCharleen M L Chan Wah Hak, Antonio Rullan, Emmanuel C Patin, et al.
Cancer Treatment Reviews|May 31, 2024
A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapiesPablo Jiménez-Labaig, Antonio Rullan, Alberto Hernando-Calvo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 25, 2024
Prevalence of depressive and anxiety symptoms in patients with head and neck cancer undergoing radiotherapy: A systematic review and meta-analysis of longitudinal studiesPablo Jiménez-Labaig, Claudia Aymerich, Antonio Rullan, et al.
JNCI Cancer Spectrum|May 3, 2024
A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysisPablo Jimenez-Labaig, Claudia Aymerich, Irene Braña, et al.
Journal for Immunotherapy of Cancer|November 28, 2025
Second-event endpoints (EFS2, PRFS2 and PFS2) after anti-PD-(L)1-based RCTs: a systematic review and meta-analysisPablo Jimenez-Labaig, Oriol Mirallas, Ana Isabel Martin-Quesada, et al.
Nature Cell Biology|June 3, 2020
STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapyEsther N Arwert, Emma L Milford, Antonio Rullan, et al.
Pageof 3